Shares of Open Orphan Plc (LON:ORPH – Get Free Report) were up 5.3% during mid-day trading on Tuesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares changed hands during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Stock Performance
The company has a market capitalization of £67.09 million and a price-to-earnings ratio of -25.30. The firm has a fifty day simple moving average of GBX 10 and a 200 day simple moving average of GBX 10. The company has a debt-to-equity ratio of 10.88, a current ratio of 1.19 and a quick ratio of 1.16.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than Open Orphan
- Using the MarketBeat Dividend Yield Calculator
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Stock Sentiment Analysis: How it Works
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Read Stock Charts for Beginners
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.
